Have a personal or library account? Click to login
SARS CoV-2 in tumor tissue in glioblastoma patients – preliminary study Cover

SARS CoV-2 in tumor tissue in glioblastoma patients – preliminary study

Current Issues in Pharmacy and Medical Sciences
Volume 37 (2024): Issue 4 (December 2024)
By: Michal Brzozowski,  Marcin Kolesnik,  Aleksander Michalski,  Katarzyna Drop and  Malgorzata Polz-Dacewicz  
Open Access
|Nov 2024

Authors

Michal Brzozowski

Neurosurgery Department, 1st Clinical Military Hospital with Outpatient Clinic, Lublin, Poland

Marcin Kolesnik

marcinkolesnik@umlub.pl

Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, Poland

Aleksander Michalski

Neurosurgery Department, 1st Clinical Military Hospital with Outpatient Clinic, Lublin, Poland

Katarzyna Drop

Department of Language, Rhetoric and Media Law, Institute of Journalism and Management, Faculty of Social Sciences, Catholic University of Lublin John Paul II, Poland

Malgorzata Polz-Dacewicz

Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, Poland
DOI: https://doi.org/10.2478/cipms-2024-0035 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 216 - 220
Submitted on: Feb 10, 2024
|
Accepted on: Oct 20, 2024
|
Published on: Nov 28, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
SARS-CoV-2,
glioblastoma,
SARS-CoV-2 antibody,
COVID-19
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2024 Michal Brzozowski, Marcin Kolesnik, Aleksander Michalski, Katarzyna Drop, Malgorzata Polz-Dacewicz, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 37 (2024): Issue 4 (December 2024)Next article